Search

everythinglearnresearchcommunity

for

Search:↓

A protein combining parathyroid hormone and collagen helped hair regrow in mice with a hair loss condition.

Herbal medicine might be a good alternative for treating hair loss.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Large doses of glucocorticoids are not suitable for general use in treating severe alopecia areata due to inconsistent results and risks.

Alopecia areata can cause unpredictable hair loss, and treatments like corticosteroids and minoxidil may help but have varying side effects.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Topical corticosteroids are the best initial treatment for children's alopecia areata.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

Alitretinoin may help treat alopecia areata.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Childhood Alopecia Areata causes hair loss and requires varied treatments, with psychological support being crucial.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Tildrakizumab may cause alopecia areata, but stopping it and using corticosteroids can regrow hair.

Yoga Prana Vidya healing can effectively treat hair loss in children.

Yoga Prana Vidya healing can effectively treat hair loss in children.

Microneedling can effectively promote hair regrowth in alopecia areata.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

Baricitinib is a promising treatment for severe alopecia areata with minimal side effects.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Squaric acid dibutylester led to complete hair regrowth in 28.5% of patients with alopecia areata.

3% topical minoxidil effectively treats extensive alopecia areata.

Diphencyprone helped most patients with alopecia areata regrow some hair.

Topical immunotherapy can treat alopecia areata, but its effectiveness varies and the exact mechanism is unclear.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Using a nonablative fractional laser with topical minoxidil can effectively and safely promote hair regrowth in alopecia areata patients.

Mogamulizumab can cause hair loss and skin rashes.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

The analysis aims to identify the most effective and safest treatments for alopecia areata.